Learn / IBRX
NASDAQ: IBRX
ImmunityBio (IBRX) stock, explained like you're 5
ImmunityBio trades on the Nasdaq under the ticker IBRX. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 11.1 billion dollars.
- Ticker
- IBRX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Large cap, about 11.1 billion dollars
Is ImmunityBio a small, medium or large cap company?
Yes. ImmunityBio is a large cap stock. Its market cap, which is the total value of all its shares, is about 11.1 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How ImmunityBio makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves IBRX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- IBRX Stock Heads For Best Week In Over 2 Months After Chairman Soon Shiong’s Cancer Vaccine Trial Milestone Update (Stocktwits)
- IBRX Stock Rallies After FDA Clears Broader Anktiva Use In Bladder Cancer Months Ahead Of Deadline (Yahoo Finance)
- ImmunityBio Stock Climbs Thursday: What's Going On? (Benzinga)
- (IBRX) Price Dynamics and Execution Aware Positioning (Stock Traders Daily)
- ImmunityBio Stock In Focus After FDA Expands Anktiva Bladder Cancer Approval (Simply Wall Street)
Follow IBRX in your daily brief
Each trading day at 5 PM ET we post what happened to ImmunityBio and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow IBRX
Questions about ImmunityBio stock
What does ImmunityBio do?
ImmunityBio trades on the Nasdaq under the ticker IBRX. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 11.1 billion dollars.
What is the ticker symbol for ImmunityBio?
ImmunityBio trades under the ticker IBRX on the Nasdaq.
What is ImmunityBio's market cap?
ImmunityBio is a large cap stock with a market cap of about 11.1 billion dollars.
How does ImmunityBio make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves IBRX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow IBRX stock every day?
Add IBRX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.